Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse Read more
InxMed Raised $15 million in Series B+ Financing to Advance Innovative Therapies to Drug-resistant Cancers Read more
Citius Pharmaceuticals to Accelerate Phase 3 Mino-Lok Trial by Expanding Trial Sites Internationally Read more
ADVANZ PHARMA to acquire Intercept’s business in Europe, Canada, and all other markets outside of the U.S. Read more
Orion enters into exclusive agreement with Jemincare for novel non-opioid drug candidate for the treatment of pain Read more
Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application (sNDA) for MYFEMBREE® for the Management of Moderate to Severe Pain Associated With Endometriosis Read more
Novartis receives European Commission approval for Jakavi to be the first post-steroid treatment for acute and chronic graft-versus-host disease Read more